# Effects of Myo-inositol in Women With Polycystic Ovary Syndrome

> **NCT04892186** · NA · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 60 (actual)

## Conditions studied

- Polycystic Ovary Syndrome
- Resistance, Insulin
- Glucose Intolerance

## Interventions

- **DRUG:** Myo-inositol
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT04892186
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-26
- **Primary completion:** 2023-10-20
- **Final completion:** 2023-10-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04892186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04892186, "Effects of Myo-inositol in Women With Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04892186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*